ANNEX 1 OBJECTIVES. At the completion of the training period, the fellow should be able to:

Similar documents
ESSO ACCREDITED TRAINING FELLOWSHIP IN BREAST SURGERY

RUTGERS CANCER INSTITUTE OF NEW JERSEY - ROBERT WOOD JOHNSON MEDICAL SCHOOL INTERDISCIPLINARY BREAST SURGERY FELLOWSHIP CORE EDUCATIONAL OBJECTIVES

Classification System

Educational Goals and Objectives for Rotations on: Breast, Wound and Plastic Surgery

Certified Breast Care Nurse (CBCN ) Test Content Outline (Effective 2018)

National Center of Oncology - Yerevan, Armenia

HOSPITAL MODELO - LA CORUÑA, Spain

Barlavento Medical Centre - Portimão, Portugal

Breast Unit - University of Heidelberg - Heidelberg, Germany

Advances in Breast Surgery. Catherine Campo, D.O. Breast Surgeon Meridian Health System April 17, 2015

Mamma Centrum / Zelený Pruh - Prague, Czech Republic

University Clinical Center Banja Luka, Breast Center - Banja Luka, Bosnia and Herzegovina

Jessa Hospital - Hasselt, Belgium

San Donato Hospital - Azienda USL TOSCANA SUDEST Arezzo - Arezzo, Italy

Guven Hospital - Ankara, Turkey

Clinica Medellin - Medellin, Colombia

Breast Cancer. Most common cancer among women in the US. 2nd leading cause of death in women. Mortality rates though have declined

Breast Cancer. Saima Saeed MD

Civic Hospital of Sanremo ASL 1 Imperiese - Sanremo, Italy

Alexandrovska Hospital - Sofia, Bulgaria

Hospital Universitari La Fe - Valencia, Spain

Breast Cancer Diagnosis, Treatment and Follow-up

Advances in Localized Breast Cancer

Ippocration Hospital University of Athens - Athens, Greece

Groote Schuur Academic Hospital - Cape Town, South Africa

Breast Clinica de la Mama and Italian Hospital - La Plata, Argentina

National Breast Cancer Audit next steps. Martin Lee

Dyson Center for Cancer Care - Poughkeepsie, New York, United States of America

Brustzentrum Universitaets Frauenklinik Tuebingen

Cork University Hospital - Cork, Ireland

Breast Surgery When Less is More and More is Less. E MacIntosh, MD June 6, 2015

Tata Memorial Hospital - Mumbai, India

Complete breast care from the team that cares. Breast Center

How can surgeons help the Radiation Oncologists?

Breast Cancer Update 2018 The Latest in Diagnosis and Treatment SARATH K, PALAKODETI, DO, FAACS GENERAL, BREAST, AND COSMETIC SURGEON TOLEDO CLINIC

THE BREAST CENTER AT MONTEFIORE NYACK HOSPITAL

Azienda Ospedaliera 'Santa Maria' Terni - Terni, Italy

Nicosia, Cyprus. Nicosia General Hospital/Bank of Cyprus Oncology Centre 1/6. General Information

Lesion Imaging Characteristics Mass, Favoring Benign Circumscribed Margins Intramammary Lymph Node

Ospedale Perrino - Brindisi, Italy

BREAST CANCER SURGERY. Dr. John H. Donohue

Chris Hani Baragwanath Academic Hospital - Johannesburg, South Africa

AZ Sint-Lucas Brugge - Brugge, Belgium

Breast Surgery: Yesterday, Today and Tomorrow

Groupe Hospitalier Avicenne-Jean Verdier, CHU de Paris-Seine-Saint-Denis - Bobigny, France

- Pisa, Italy. Azienda Ospedaliero-Universitaria Di Pisa - Ospedale S. Chiara 1/6. General Information

Breast Cancer Pathway Map

Waterford Regional Hospital - Waterford City, Ireland

Athens Euroclinic - Athens, Greece

Surgical Therapy: Sentinel Node Biopsy and Breast Conservation

Alfa Cure Oncology Center - Cairo, Egypt

BREAST SURGERY - SYLLABUS 2014

Military Medical Academy Sofia - Sofia, Bulgaria

Surgical Oncology/Clinical Center Sarajevo - Sarajevo, Bosnia and Herzegovina

Brustzentrum Marienhospital Bottrop - Bottrop, Germany

Azienda Ospedaliera Sant'Anna - San Fermo della Battaglia, Italy

Detailed Program of the second BREAST IMAGING AND INTERVENTIONS PROGRAM am am : Clinician s requirements from breast imaging

Centro Donna, Ospedale Montecchio Maggiore - Montecchio Maggiore, Italy

Breast cancer reconstruction surgery (immediate and delayed) across Ontario: Patient indications and appropriate surgical options

Prolipsis Breast Unit - Athens, Greece

Cairo Oncology Center - Giza, Egypt

Radioactive Seed Localization of Nonpalpable Breast Lesions

METAXA CANCER HOSPITAL - PIRAEUS, Greece

University Hospital for Tumors, University Hospital Center Sestre Milosrdnice - Zagreb, Croatia

Quality ID #263: Preoperative Diagnosis of Breast Cancer National Quality Strategy Domain: Effective Clinical Care

Breast Cancer. What is breast cancer?

Maria João Cardoso, MD, PhD

Guideline for the Management of Patients Suitable for Immediate Breast Reconstruction

Smilow Cancer Hospital at Yale-New Haven - New Haven, United States

CURRENT METHODS IN IMAGE GUIDED BREAST BIOPSY

Evolution of Breast Surgery

BREAST CANCER CARE IN RESOURCE CONSTRAINED REGIONS BBCC 2017 DHAKA. M.J.PAUL MS,DNB, FRCS (Glasg) Professor, Endocrine Surgery CMC Vellore, India

Evaluation of the Axilla Post Z-0011 Trial New Paradigm

Case Scenario 1. 2/15/2011 The patient received IMRT 45 Gy at 1.8 Gy per fraction for 25 fractions.

Arcispedale Santa Maria Nuova - Reggio Emilia, Italy

Humanitas Mater Domini - Castellanza, Italy

Case Scenario 1 History and Physical 3/15/13 Imaging Pathology

GOALS AND OBJECTIVES BREAST PATHOLOGY

One Breast Cancer Annual Report

Istituto Clinico S. Anna - Brescia, Italy

Position Statement on Management of the Axilla in Patients with Invasive Breast Cancer

Centro Mamario del Hospital Universitario Austral - Derqui, Partido de Pilar, Argentina

Brustzentrum Mittelland Kantonsspitäler Aarau/Olten - Aarau, Switzerland

What is Cancer? Petra Ketterl, MD Medical Oncology and Functional Medicine

University Hospital 'Tsaritza Yoanna - ISUL' - Sofia, Bulgaria

Unità di Senologia Ospedale Valduce - Como, Italy

FY16 BCCS Reimbursement Rates and Billing Guidelines Appendix B 2

Candiolo Cancer Institute - FPO, IRCCS - Candiolo, Italy

Consensus Guideline on Image-Guided Percutaneous Biopsy of Palpable and Nonpalpable Breast Lesions

University of Szeged - Dept. of Oncotherapy - Szeged, Hungary

West Hertfordshire Hospital NHS Trust - Watford, United Kingdom

Tata Medical Center - Kolkata, West Bengal, India

Breast Cancer Imaging

Marienhospital Aachen - Brustcentrum - Aachen, Germany

Istanbul, Turkey. Istanbul University Cerrahpasa Medical Faculty Breast Center 1/6. General Information

The Case FOR Oncoplastic Surgery in Small Breasts. Barbara L. Smith, MD, PhD Massachusetts General Hospital Harvard Medical School Boston, MA USA

Breast cancer: an update

A Decade of Change: An Institutional Experience with Breast Surgery in 1995 and 2005

It is a malignancy originating from breast tissue

Transcription:

1 ANNEX 1 OBJECTIVES At the completion of the training period, the fellow should be able to: 1. Breast Surgery Evaluate and manage common benign and malignant breast conditions. Assess the indications and contraindications for, and demonstrate experience in the performance and interpretation of the results of common procedures, including but not limited to cyst aspiration, fine needle aspiration, percutaneous core biopsy with and without image guidance, punch biopsy of skin. Assess the indications for techniques to optimize cosmetic outcome, minimize surgical trauma, and achieve best oncologic outcome for cancer operations for all major breast procedures, including but not limited to: a) Breast conservation- indications and contraindications - The predicted aesthetic outcome after breast conservation - The role of neoadjuvant systemic treatment in facilitating breast conservation, including indications and contraindications as well as evaluating the response - Assessing margin width and ways to improve negative margins - Impact of margins on local recurrence and survival - Methods to correct poor aesthetic outcome after breast conservation Techniques Advantages and disadvantages of various localization methods - Wide local excision, lumpectomy, guided wire localization - IOUS (intraoperative ultrasound guided surgery) - ROLL (radioguided occult lesion localization) - RSL (radioguided seed localization)

2 Breast Conservative Oncoplastic techniques Level I and level II oncoplastic techniques in breast conservation b) Mastectomy and Reconstruction. Indications and techniques (Simple, skin sparing, nipple sparing) Types of reconstruction- implant and autologous Factors influencing aesthetic outcome after breast reconstruction - Oncological safety of immediate and delayed reconstruction - Influence of reconstruction on the patient s quality of life c) Sentinel node biopsy (SNB) The sentinel node concept (Injection techniques and type of isotopes) The indications and contraindications of SNB d) Axillary lymph node dissection (ALND) - Anatomy of the axilla - The indications and contraindications of ALND - Arm Reverse Mapping Demonstrate proficiency in interdisciplinary evaluation and pre-surgical treatment planning with multiple disciplines, including but not limited to radiology, plastic and reconstructive surgery, medical oncology, radiation oncology, medical oncology and pathology Identify the indications for and techniques of palliative surgical procedures for locoregional relapse as well as surgical management of primary breast tumor in Stage IV breast cancer. Evaluate and manage arm lymphedema as a side effect of breast cancer treatment. Each breast fellow must participate in a minimum of 50 operative procedures (as surgeon or first assistant). The experience should include diagnostic biopsies, partial mastectomies, mastectomies, axillary node dissections, sentinel node biopsies, and reconstructive procedures. In addition to open breast procedures, experience with stereotactic and ultrasound guided breast biopsy is desirable.

3 2. Breast Imaging Understand the techniques of diagnostic mammography, including the BI-RADS nomenclature, recommendations for additional views, and identify mammographic characteristics of benign and malignant disease. Understand the basics of breast ultrasound, and distinguish normal breast sonographic anatomy, sonographic characteristics of simple cysts, complex cysts, well-circumscribed probably benign mass, and solid mass of suspicious nature. Demonstrate training in performance of image-guided biopsy techniques. Demonstrate experience in selecting image-guided breast intervention procedures, including but not limited to, ductograms, image-guided (i.e., ultrasound, stereotactic, MRI and others) fine needle aspiration, and core biopsies. Discuss the evolving breast imaging technologies. Evaluate the present indications for and possible future applications of MRI in the management of malignant and benign breast disease. Explain evolving surgical technologies such as percutaneous ablation, core vacuum resection. Discuss the complexities, advantages and disadvantages of breast screening in women at different age groups. 3. Genetics Identify patients at high risk for developing breast cancer, including risk factors such as pathologic, familial, genetic, and previous cancer inducing therapies (i.e., childhood radiation). Discuss the epidemiological evidence of the effect of environmental factors (broadly defined as nutrition, lifestyle, pollutants, chemicals, social economic status, etc.) on high-risk patients. Advise patients regarding estimations of risk by contemporary models and risk reduction by screening, medication, and surgery. Review the available clinical trials for breast cancer risk reduction and facilitate the option of participation in such trials. Advise patients regarding indications, usefulness, costs, complications and privacy issues of genetic testing.

4 Interpret the various pathology findings as they influence risk. Describe and evaluate surgical options in patients suspected of an inherited susceptibility. Identify resources available for genetic testing and counseling. 4. Medical Oncology Assess the indications and contraindications for adjuvant systemic chemotherapy and hormonal therapies. Describe the mechanism of action; risks, benefits and indications of existing and developing targeted therapies. Describe the prominent molecular pathways in the development and progression of breast cancer. Describe the most commonly prescribed chemotherapy and hormonal agents and their associated acute and chronic toxicities. Identify toxicities of prescribed agents. Identify indications, techniques and interdisciplinary coordination required for neoadjuvant treatments. Demonstrate experience in the interdisciplinary management of recurrent and metastatic disease including palliative care 5. Pathology Explain the benign and malignant pathological aspects of breast disease. Understand optimal techniques for orienting, processing and assessing the pathology specimen. Explain and evaluate immunohistochemical stains, cytology, and tumor markers and other indicators of prognosis that are relevant to treatment. Discuss evolving pathology technology (molecular techniques,etc) and intraoperative indications. Knowledge of the different genomic platforms (Mammaprint, Oncotype, PAM 50 ) and indications for its use. Stage breast cancer clinically and pathologically.

5 6. Plastic and Reconstructive Surgery Demonstrate an understanding of reconstructive and surgical procedures such as: Tissue expander, implant, and a variety of flap reconstruction techniques for immediate and delayed reconstruction in the setting of post mastectomy reconstructive surgery. Understand the general breast plastic procedures such as augmentation and reduction as they relate to total management of women with benign and malignant breast disease. Explain and evaluate the interrelationship of adjuvant therapies on planning and timing of plastic and reconstructive surgery. 7. Psycho-Oncology Recognize needs for social support systems for patients and their families throughout diagnosis, treatment, and transition to surveillance, and relapse. Recognize cultural diversity and the different needs of patients and their families with regard to illness and treatment. Recognize patients at psychosocial high risk and identify resources for referral. Discuss complementary therapies/integrated care. 8. Radiation Oncology Understand the process the patient experiences undergoing radiation therapy to the breast, including: simulation, treatment planning, treatment delivery, and acute and chronic effects of therapy. Assess the indications and contraindications for and complications of post breast conservation radiation therapy in both ductal carcinoma in situ and invasive carcinomas, post mastectomy radiation therapy. The management of chest wall recurrences. Knowledge of the indications for nodal basins radiation therapy as well as side effects Assess the impact of radiation therapy on various surgical options for reconstruction. Discuss the evolving technologies of partial breast irradiation (intraoperative radiation therapy, Conformational 3D, brachytherapy )

6 9. Research Clinical experience alone is insufficient education in the breast fellowship training. Fellows must participate in regularly scheduled programs, such as conferences, lectures, journal clubs, multidisciplinary case conferences and multidisciplinary CME meetings. The didactic experience should include clinical breast problems, but also translational science, clinical research, and ethical problems The fellow should be able to participate in: Clinical trials development and patient enrollment and prospective and retrospective clinical research. Enrollment in patients in available national protocols. The conduct and critical review of research studies. The preparation of manuscripts suitable for publication Additional Essential Training. In order to accomplish with the objectives, the fellowship must provide exposure to and experience in the multidisciplinary management of breast disorders. The fellowship must provide opportunities to participate in multidisciplinary clinics, tumor boards, or conferences. Required non surgical rotations include but not limited to: Radiation Oncology - One month dedicated to learning the principles and practice of radiotherapy, as related to the multidisciplinary management of breast cancer as outlined in the educational objectives. Surgical Pathology - One-month rotation in the surgical pathology department or a documented equivalent exposure encompassing benign and malignant histology Medical Oncology - A minimum of one month dedicated to medical oncology. Fellows should gain experience in evaluating and managing patients receiving chemotherapy, and hormonal therapy. The rotation may be done during the whole month or distributed during the Fellowship program depending on Institutions.